Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
PulmonaryAsthma

Asthma

What's New from AJM

Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector

0
  Anaphylaxis is a life-threatening condition, with at-risk individuals remaining at chronic high risk of recurrence. Anaphylaxis is frequently underrecognized and undertreated by healthcare providers. The first-line pharmacologic intervention for anaphylaxis is epinephrine, and guidelines uniformly agree that its prompt administration is vital to prevent progression, improve patient outcomes, and reduce hospitalizations and fatalities. Healthcare costs potentially associated with failure...